Marvin & Palmer Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$9.53M |
| 2 |
Walmart Inc
WMT
|
+$8.17M |
| 3 |
Deere & Co
DE
|
+$7.82M |
| 4 |
Enphase Energy
ENPH
|
+$7.26M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$1.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palo Alto Networks
PANW
|
+$7.81M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$7.28M |
| 3 |
Synopsys
SNPS
|
+$7.23M |
| 4 |
UnitedHealth
UNH
|
+$1.82M |
| 5 |
iShares MSCI Indonesia ETF
EIDO
|
+$1.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.48% |
| 2 | Healthcare | 20.76% |
| 3 | Industrials | 20.4% |
| 4 | Technology | 11.42% |
| 5 | Consumer Discretionary | 6.06% |
Similar funds
Marvin & Palmer Associates's Q4 2022 Portfolio in Review
As of Q4 2022, Marvin & Palmer Associates held 32 positions worth $190M, up 17% from $163M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Marvin & Palmer Associates deployed $12.9M of net new capital in Q4 2022, opening 7 new positions and adding to 10 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 53,607 shares worth $9.35M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was UnitedHealth, an estimated $1.82M trimmed.
- Marvin & Palmer Associates's largest Q4 2022 buy was iShares Russell 2000 ETF: 53,607 shares worth $9.35M.
- Marvin & Palmer Associates added most to Charles Schwab in Q4 2022, an estimated $1.29M increase.
- Marvin & Palmer Associates's biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $1.82M.
- Marvin & Palmer Associates fully exited Palo Alto Networks in Q4 2022, selling an estimated $7.81M.
- Marvin & Palmer Associates's ten largest holdings make up 52% of its $190M portfolio in Q4 2022.
- Marvin & Palmer Associates opened 7 new positions and closed 5 in Q4 2022.
- Marvin & Palmer Associates's portfolio value rose 17% quarter-over-quarter to $190M.
Based on Marvin & Palmer Associates's 13F filing for Q4 2022, filed 14 Feb 2023.